Minot State University
Minot, North Dakota, 58707, United States
NCT Number: NCT06612983
The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy tissue of adult volunteers. The main questions it aims to answer are:
* Does IASTM treatment have an effect on range of motion (ROM) as measured in the ankle and knee? * Does IASTM treatment have an effect on movement patterns including gait - how a person walks? Researchers will compare pre-test and post-test data from the same individual on their day with treatment to the pre-test and post-test data from the same individual on their day without treatment to see if ROM or gait are effected by use of IASTM.
Participants will:
* Complete a past medical and injury history questionnaire * Have ankle and knee range of motion (ROM) measurements taken on both lower extremities using a goniometer * Undergo a gait analysis to determine center of gravity, center of pressure, step length, stride length, and stride frequency using Noraxon MyoMuscle Ultium Insoles * Undergo IASTM treatment techniques using the HawkGrips tools including applying emollient to the skin to reduce friction on the surface followed by scanning the gastroc/soleus complexes and Achilles tendons using the HG8-Scanner tool for 15 strokes in each direction to identify areas of concern, then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction. Treatment techniques should last for 10 minutes in total on each side. * Complete the ankle and knee ROM measurements as well as gait analysis again to document progress at the end of the first session. * Return three to seven days after the first session in which the subject will have the walking treatment. * Undergo the same baseline pre-test measurements for range of motion and gait analysis as the first session * Experience the walking treatment by walking for the same time period that the IASTM treatment took at the first session * Undergo the post-test range of motion and gait analysis for data comparison.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Minot, North Dakota, 58707, United States
No further information to note than what is described in the summary or elsewhere
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Instrument assisted soft tissue mobilization is a technique that is applied using specially designed tools/instruments to provide a mobilizing effect to soft tissues including the skin, fascia, muscles, and tendons by its various direct compressive stroke techniques on the gastroc/soleus complexes and Achilles tendons in the first session.
Other names: HawkGrips
Movement itself should promote mobility so walking steadily for the same period of time as the IASTM had taken to complete is the sham treatment in second session.
Time frame: From baseline to end of session at one hour
Bilateral knee flexion and extension as well as ankle plantarflexion, dorsiflexion, inversion and eversion range of motion measurements were taken in supine using a goniometer.
Time frame: From baseline to end of session at one hour
Gait analysis was conducted using Noraxon MyoMuscle System with Ultium insoles placed in the participants shoes. The software collected data on center of gravity, center of pressure, step length, stride length, and stride frequency.
Beth Marschner
Other
Acronym: (IASTM)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details